Crossmark

Developing sero-diagnostic tests to facilitate Plasmodium vivax Serological Test-and-Treat approaches: modeling the balance between public health impact and overtreatment

Crossref DOI link: https://doi.org/10.1186/s12916-022-02285-5

Published Online: 2022-03-18

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Obadia, Thomas

Nekkab, Narimane

Robinson, Leanne J.

Drakeley, Chris

Mueller, Ivo

White, Michael T.
Funding

Funding for this research was provided by:

Bill and Melinda Gates Foundation (INV009103)

Bill and Melinda Gates Foundation (INV024368)

National Health and Medical Research Council (GNT1102297)

National Health and Medical Research Council (GNT1171795)

National Health and Medical Research Council (GNT1155075)

National Health and Medical Research Council (GNT1161627)

National Institutes of Health (1U19AI129392-01)

Agence Nationale de la Recherche (ANR-10-LABX-62-IBEID)

Agence Nationale de la Recherche (ANR-16-CONV-0005)
License Information

Text and Data Mining valid from 2022-03-18

Version of Record valid from 2022-03-18
More Information

Article History

Received: 26 October 2021

Accepted: 7 February 2022

First Online: 18 March 2022

Declarations

:

: Not applicable

: All authors read and approved the final manuscript.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below